Chief Executive, Starpharma
| Role | Organisation | Sources |
|---|---|---|
| Chief Executive | Starpharma | Biotech Dispatch (26 Aug 2026), Biotech Dispatch (16 Jul 2026), kalkine.com.au, @AuManufacturing |
Stories naming Cheryl Maley. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne biotech Starpharma grew annual revenue on a Genentech licence payment, cut its loss, and completed a $30 million entitlement offer, giving it cash into 2028 to advance its cancer pipeline.
Australian biotech Starpharma has opened a 57-cent shareholder rights issue seeking about $32 million, with Canaccord Genuity underwriting the raise and an oversubscription facility letting holders apply for extra shares.
Also Biotech Dispatch·tipranks.com·kalkine.com.au·Biotech Dispatch
Briefs roundup: Main Sequence adds Alison Deans as venture partner; Starpharma hands the CEO role to Cheryl Maley; DroneShield lands a $2.2 million repeat order; Q-CTRL will deliver quantum training with QUIN.